147 related articles for article (PubMed ID: 38403146)
21. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
22. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
[TBL] [Abstract][Full Text] [Related]
23. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression.
Clos-Garcia M; Loizaga-Iriarte A; Zuñiga-Garcia P; Sánchez-Mosquera P; Rosa Cortazar A; González E; Torrano V; Alonso C; Pérez-Cormenzana M; Ugalde-Olano A; Lacasa-Viscasillas I; Castro A; Royo F; Unda M; Carracedo A; Falcón-Pérez JM
J Extracell Vesicles; 2018; 7(1):1470442. PubMed ID: 29760869
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.
Henrich SE; McMahon KM; Plebanek MP; Calvert AE; Feliciano TJ; Parrish S; Tavora F; Mega A; De Souza A; Carneiro BA; Thaxton CS
J Extracell Vesicles; 2020 Dec; 10(2):e12042. PubMed ID: 33408816
[TBL] [Abstract][Full Text] [Related]
25. CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer.
Su Z; Wang G; Li L
Cancer Biomark; 2023; 38(2):143-159. PubMed ID: 37781794
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N
Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531
[TBL] [Abstract][Full Text] [Related]
27. Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.
Pellegrini KL; Patil D; Douglas KJS; Lee G; Wehrmeyer K; Torlak M; Clark J; Cooper CS; Moreno CS; Sanda MG
Prostate; 2017 Jun; 77(9):990-999. PubMed ID: 28419548
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
[TBL] [Abstract][Full Text] [Related]
29. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
[TBL] [Abstract][Full Text] [Related]
30. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
31. Systematic Analysis of Tissue-Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer.
Larson J; Ozen MO; Kohli M; Akin D; Demirci U
Adv Biol (Weinh); 2023 Jul; 7(7):e2200327. PubMed ID: 37300338
[TBL] [Abstract][Full Text] [Related]
32. One-Step Thermophoretic AND Gate Operation on Extracellular Vesicles Improves Diagnosis of Prostate Cancer.
Deng J; Zhao S; Li J; Cheng Y; Liu C; Liu Z; Li L; Tian F; Dai B; Sun J
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202207037. PubMed ID: 35749531
[TBL] [Abstract][Full Text] [Related]
33. PSA reactivity in extracellular microvesicles to commercial immunoassays.
Sandúa A; Sanmamed MF; Rodríguez M; Ancizu-Marckert J; Gúrpide A; Perez-Gracia JL; Alegre E; González Á
Clin Chim Acta; 2023 Mar; 543():117303. PubMed ID: 36948237
[TBL] [Abstract][Full Text] [Related]
34. Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis.
Shin H; Park YH; Kim YG; Lee JY; Park J
PLoS One; 2018; 13(3):e0194818. PubMed ID: 29584777
[TBL] [Abstract][Full Text] [Related]
35. Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.
Bryzgunova OE; Zaporozhchenko IA; Lekchnov EA; Amelina EV; Konoshenko MY; Yarmoschuk SV; Pashkovskaya OA; Zheravin AA; Pak SV; Rykova EY; Laktionov PP
PLoS One; 2019; 14(4):e0215003. PubMed ID: 30970027
[TBL] [Abstract][Full Text] [Related]
36. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
[TBL] [Abstract][Full Text] [Related]
37. miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.
Gunawan RR; Astuti I; Danarto HR
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1095-1099. PubMed ID: 36974566
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
[TBL] [Abstract][Full Text] [Related]
39. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.
Li J; Ren S; Piao HL; Wang F; Yin P; Xu C; Lu X; Ye G; Shao Y; Yan M; Zhao X; Sun Y; Xu G
Sci Rep; 2016 Feb; 6():20984. PubMed ID: 26865432
[TBL] [Abstract][Full Text] [Related]
40. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]